AAAAAA

   
Results: 1-21 |
Results: 21
Nerve-sparing radical retropublic prostatectomy. Outcome analysis based onpatient questionnaires
Authors: Noldus, J Michl, U Graefen, M Haese, A Hammerer, P Fernandez, S Huland, H
Citation: J. Noldus et al., Nerve-sparing radical retropublic prostatectomy. Outcome analysis based onpatient questionnaires, UROLOGE A, 40(2), 2001, pp. 102
Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients
Authors: Conrad, S Hautmann, SH Henke, RP Erbersdobler, A Simon, J Straub, M Graefen, M Hautmann, RE Huland, H
Citation: S. Conrad et al., Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients, EUR UROL, 39, 2001, pp. 25-29
High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens
Authors: Prange, W Erbersdobler, A Hammerer, P Graefen, M Hautmann, SH Hautmann, RE Huland, H Henke, RP
Citation: W. Prange et al., High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens, EUR UROL, 39, 2001, pp. 30-31
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml
Authors: Haese, A Graefen, M Steuber, T Becker, C Pettersson, K Piironen, T Noldus, J Huland, H Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, PROSTATE, 49(2), 2001, pp. 101-109
A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis
Authors: Lein, M Jung, K Hammerer, P Graefen, M Semjonow, A Stieber, P Ossendorf, M Luboldt, HJ Brux, B Stephan, C Schnorr, D Loening, SA
Citation: M. Lein et al., A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis, PROSTATE, 47(2), 2001, pp. 77-84
Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens
Authors: Prange, W Erbersdobler, A Hammerer, P Graefen, M Hautmann, SH Hautmann, RE Huland, H Henke, RP
Citation: W. Prange et al., Significance of high-grade prostatic intraepithelial neoplasia in needle biopsy specimens, UROLOGY, 57(3), 2001, pp. 486-490
A validated strategy for side specific prediction of organ confined prostate cancer: A tool to select for nerve sparing radical prostatectomy
Authors: Graefen, M Haese, A Pichlmeier, U Hammerer, PG Noldus, J Butz, K Erbersdobler, A Henke, RP Michl, U Fernandez, S Huland, H
Citation: M. Graefen et al., A validated strategy for side specific prediction of organ confined prostate cancer: A tool to select for nerve sparing radical prostatectomy, J UROL, 165(3), 2001, pp. 857-863
Mucin-positive adenocarcinoma of the urachus. A case report and review of the literature
Authors: Reek, C Graefen, M Erbersdobler, A Haese, A
Citation: C. Reek et al., Mucin-positive adenocarcinoma of the urachus. A case report and review of the literature, UROLOGE A, 39(6), 2000, pp. 572-575
Chemoprevention of prostate cancer
Authors: Hammerer, P Graefen, M Steuber, T Huland, H
Citation: P. Hammerer et al., Chemoprevention of prostate cancer, UROLOGE A, 39(4), 2000, pp. 304-308
Therapy options for hormon-refractory carcinoma of the prostate
Authors: Graefen, M Hammerer, P Haese, A Huland, H
Citation: M. Graefen et al., Therapy options for hormon-refractory carcinoma of the prostate, UROLOGE A, 39(3), 2000, pp. 267-273
Mixed squamous-cell carcinoma with adenocarcinoma of the female urethra. Acase report
Authors: Reek, C Graefen, M Noldus, J Fernandez, S
Citation: C. Reek et al., Mixed squamous-cell carcinoma with adenocarcinoma of the female urethra. Acase report, UROLOGE A, 39(2), 2000, pp. 174-177
Prognostic markers for prostate cancer
Authors: Graefen, M Hammerer, P Noldus, J Haese, A Pichelmeier, U Erbersdobler, A Henke, H Conrad, S Fernandez, S Huland, H
Citation: M. Graefen et al., Prognostic markers for prostate cancer, UROLOGE A, 39(1), 2000, pp. 14-21
Advanced prostate cancer is associated with a decrease in serum luteinizing hormone
Authors: Hilz, H Graefen, M Noldus, J Hammerer, P Knabbe, C Huland, E Huland, H
Citation: H. Hilz et al., Advanced prostate cancer is associated with a decrease in serum luteinizing hormone, EUR UROL, 38(3), 2000, pp. 243-249
Stage migration in clinically localized prostate cancer
Authors: Noldus, J Graefen, M Haese, A Henke, RP Hammerer, P Huland, H
Citation: J. Noldus et al., Stage migration in clinically localized prostate cancer, EUR UROL, 38(1), 2000, pp. 74-78
Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy
Authors: Hammerer, P Graefen, M Henke, RP Haese, A Palisaar, J Huland, E Huland, H
Citation: P. Hammerer et al., Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy, ANTICANC R, 20(6D), 2000, pp. 5253-5255
Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology
Authors: Hautmann, SH Conrad, S Henke, RP Erbersdobler, A Simon, J Straub, M Graefen, M Hautmann, RE Huland, H
Citation: Sh. Hautmann et al., Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology, J UROL, 163(6), 2000, pp. 1734-1738
Human glandular kallikrein 2: A potential serum marker for predicting the organ confined versus nonorgan confined growth of prostate cancer
Authors: Haese, A Becker, C Noldus, J Graefen, M Huland, E Huland, H Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2: A potential serum marker for predicting the organ confined versus nonorgan confined growth of prostate cancer, J UROL, 163(5), 2000, pp. 1491-1497
Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality
Authors: Erbersdobler, A Graefen, M Wullbrand, A Hammerer, P Henke, RP
Citation: A. Erbersdobler et al., Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocality, PROSTATE C, 2(4), 1999, pp. 204-210
Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics
Authors: Graefen, M Noldus, J Pichlmeier, U Haese, A Hammerer, P Fernandez, S Conrad, S Henke, RP Huland, E Huland, H
Citation: M. Graefen et al., Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics, EUR UROL, 36(1), 1999, pp. 21-30
Supersensitive PSA-analysis after radical prostatectomy: A powerful tool to reduce the time gap between surgery and evidence of biochemical failure
Authors: Haese, A Huland, E Graefen, M Huland, H
Citation: A. Haese et al., Supersensitive PSA-analysis after radical prostatectomy: A powerful tool to reduce the time gap between surgery and evidence of biochemical failure, ANTICANC R, 19(4A), 1999, pp. 2641-2644
A comparison of ureteroscopy to in situ extracorporeal shock wave lithotripsy for the treatment of distal ureteral calculi
Authors: Michl, UGH Graefen, M Huland, H
Citation: Ugh. Michl et al., A comparison of ureteroscopy to in situ extracorporeal shock wave lithotripsy for the treatment of distal ureteral calculi, J UROL, 162(6), 1999, pp. 2103-2103
Risultati: 1-21 |